further , this procedure could also be applied to the clinical phase of new drug testing to evaluate the effects of that agent with respect to aneuploidy since the increases in y chromosomal nondisjunction may well act as a barometer for increases in overall autosomal nondisjunction .
C0184661
procedure
C0220825
evaluate